Inozyme Pharma (INZY)
(Delayed Data from NSDQ)
$4.51 USD
-0.07 (-1.53%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $4.50 -0.01 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.35 per share, missing the Zacks Consensus Estimate of -$0.31 per share. This reflects a negative earnings surprise of 12.90%. Look out for INZY's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year increase of 12.5%.
Earnings History
Price & Consensus
Zacks News for INZY
Why Earnings Season Could Be Great for Inozyme (INZY)
INZY: What are Zacks experts saying now?
Zacks Private Portfolio Services